Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights
Hand-out
Press Releases
Oncolytics Biotech® Inc.  
November 12, 2024

Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights

BRACELET-1 data showing impressive overall survival benefit in HR+/HER2- metastatic breast cancer affirms pelareorep + paclitaxel combination should be evaluated in a registrational study

avatar profile Olean Times Herald

Olean Times Herald


Local & Social